We are an Oxford, UK-based business with a revolutionary computer-based platform and a unique network-driven drug discovery ("NDD") methodology which allows us to discover novel and better drugs faster.
Who we are
What we do
Read more about our cutting edge in silico techniques, the importance of network science, our strategy and our assets.
What we do
News and Media
View our regulatory announcements, read our publications, see our videos and subscribe to receive email alerts.
News & media
Investors
We are a UK-based company listed (ETX.L) on the Alternative Investment Market (AIM), London Stock Exchange's international market for smaller, growing companies.
Investors